7.40
Cullinan Therapeutics Inc Borsa (CGEM) Ultime notizie
Will Cullinan Therapeutics Inc. stock maintain dividend yieldJuly 2025 Setups & Entry Point Confirmation Signals - newser.com
Cullinan Therapeutics Inc. stock trend forecast2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com
Using data filters to optimize entry into Cullinan Therapeutics Inc.July 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
How Cullinan Therapeutics Inc. stock trades during market volatilityJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
Can Cullinan Therapeutics Inc. stock attract ESG capital inflowsTrade Ideas & Detailed Earnings Play Alerts - newser.com
Will Cullinan Therapeutics Inc. stock recover after recent dropJuly 2025 Update & Daily Entry Point Alerts - newser.com
Cullinan Therapeutics (CGEM) Reveals Promising Phase 1 Data for CLN-049 in AML and MDS - GuruFocus
Cullinan Therapeutics Inc. stock daily chart insights2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Can Cullinan Therapeutics Inc. stock beat market expectations this quarterJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
Cullinan Management Unveils Promising CLN-049 Clinical Data - TipRanks
Heatmap analysis for Cullinan Therapeutics Inc. and competitorsMarket Weekly Review & Verified Entry Point Signals - newser.com
Cullinan Therapeutics Presents New Data on CLN-049 at ASH Meeting - TradingView
Cullinan (NASDAQ: CGEM) announces 69% ORR for CLN-049 in r/r AML; Phase 1 shows manageable safety - Stock Titan
Visual analytics tools that track Cullinan Therapeutics Inc. performanceWeekly Volume Report & Weekly Chart Analysis and Guides - newser.com
Cullinan Therapeutics Inc. stock outlook for YEARJuly 2025 Movers & High Conviction Trade Alerts - newser.com
Is Cullinan Therapeutics Inc. reversing from oversold territory2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
What machine learning models say about Cullinan Therapeutics Inc.2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
Will Cullinan Therapeutics Inc. rebound enough to break evenWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com
What makes Cullinan Therapeutics Inc. stock attractive to growth fundsQuarterly Profit Report & AI Driven Price Forecasts - newser.com
Backtesting results for Cullinan Therapeutics Inc. trading strategies2025 Volume Leaders & Real-Time Volume Analysis - newser.com
Why retail investors pile into Cullinan Therapeutics Inc. stockProduct Launch & Free Reliable Trade Execution Plans - newser.com
Will Cullinan Therapeutics Inc. stock gain from government policiesEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 13.5% After Insider Buying Activity - MarketBeat
Will Cullinan Therapeutics Inc. stock return to pre crisis levelsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com
What momentum indicators show for Cullinan Therapeutics Inc. stockJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com
Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Lynx1 Capital Management Lp Purchases 165,667 Shares - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):